Effectiveness and Safety of Favipiravir Compared to Hydroxychloroquine for Management of Covid-19: A Retrospective Study-Reference-Cited by-同舟云学术

Effectiveness and Safety of Favipiravir Compared to Hydroxychloroquine for Management of Covid-19: A Retrospective Study

Published:2021-09 Issue: Volume:Volume 14 Page:5597-5606
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

Alotaibi Musim,Ali Ahmed,Bakhshwin Duaa,Alatawi Yasser,Alotaibi Sultan,Alhifany Abdullah^ORCID,Alharthi Badr^ORCID,Alharthi Nasser,Alyazidi Awatef,Alharthi Yasmeen,Alrafiah Aziza^ORCID

Publisher

Informa UK Limited

Subject

General Medicine

Reference29 articles.

1. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial

2. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of substituent effects on the electronic structure and antiviral activity of favipiravir derivatives for Covid-19 treatment using DFT and molecular docking;Scientific Reports;2024-07-31

2. Evaluation of the relationship of treatment and vaccination with prognosis in patients with a diagnosis of COVID-19;Inflammopharmacology;2024-03-16

3. Aprotinin—Drug against Respiratory Diseases;International Journal of Molecular Sciences;2023-07-06

4. Antiviral Activity of Beebread, Bee-Collected Pollen and Artificially Fermented Pollen against Influenza A Virus;Foods;2023-05-13

5. Profiles of Independent-Comorbidity Groups in Senior COVID-19 Patients Reveal Low Fatality Associated with Standard Care and Low-Dose Hydroxychloroquine over Antivirals [Letter];Journal of Multidisciplinary Healthcare;2023-05